The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19-Glimpses from an EHR-based Study.
Pamela C EganChinmay T JaniHarpreet SinghSanjay MishraJeremy L WarnerPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Multiple prior studies have shown an increased risk of severe disease and death from SARS-CoV-2 infection in patients with cancer. Nolan and colleagues conducted a multi-institution, electronic health record (EHR)-based study of adults hospitalized with COVID-19 delineating the difference in outcomes when stratified by current versus former cancer diagnosis and found that only a current diagnosis appears to confer an increased risk of severe COVID-19 and death.We review these findings in the context of other studies examining outcomes for individuals with cancer diagnoses and COVID-19. We also address questions raised by this type of study about the significant challenges of EHR-based studies and discuss potential avenues for future research in this arena. See related article by Nolan et al., p. 12.
Keyphrases
- electronic health record
- coronavirus disease
- sars cov
- papillary thyroid
- squamous cell
- respiratory syndrome coronavirus
- clinical decision support
- newly diagnosed
- ejection fraction
- case control
- lymph node metastasis
- metabolic syndrome
- squamous cell carcinoma
- prognostic factors
- young adults
- risk assessment
- patient reported outcomes
- chronic kidney disease
- weight loss